Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Thomas Callahan is Staff Physician and Director of Inpatient Services in the Section of Pacing and Electrophysiology of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. His office is located on the main campus. He came to the Cleveland Clinic in 2003 as a Fellow in Cardiovascular Medicine and subsequently also completed a Fellowship in Cardiac Electrophysiology and Pacing. He is board certified in Clinical Cardiac Electrophysiology, Cardiovascular Disease,Internal Medicine, and Nuclear Cardiology. His specialty areas include: atrial and ventricular arrhythmias including atrial fibrillation and catheter ablation for treatment of these arrhythmias including pulmonary vein isolation. He also specializes in device therapy including device and lead extraction and the implantation of pacemakers, implantable defibrillators (ICDs), and biventricular pacemakers and ICDs. He currently serves as associate program director for the cardiology and electrophysiology fellowships.
Dr. Callahan is a graduate of Ohio's Oberlin College. He received a Master's Degree from the University of Michigan, and then continued his education, earning a medical degree from Eastern Virginia Medical School, Norfolk, VA. Prior to joining the Cleveland Clinic, Dr. Callahan served as resident and then chief resident in Internal Medicine at the Hospital of the University of Pennsylvania. He has received several honors and awards, including the Dawson Award for Clinical Excellence and Humanism.
Dr. Callahan has conducted research in his areas of specialization that has been published in leading medical journals. He is a member of the Heart Rhythm Society, American College of Cardiology, and the American Medical Association.
Abnormal Heart Rhythm, Sudden Cardiac Death, Supraventricular Tachycardia, Ventricular Tachycardia, Wolff-Parkinson-White Syndrome, Biventricular Pacemaker, Catheter Ablation, Implantable Cardioverter Defibrillator, Lead Extraction, Radiofrequency ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Callahan, IV's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.